Rapid, automated subregional tracer quantification
Our research-specific component of NeuroQuant® provides researchers and physicians with a cutting-edge tool for the study of frontotemporal dementia and Alzheimer’s disease.
Insight that leads to breakthrough discoveries
Automatically quantify PET tracer bindings localized to brain structures identified by NeuroQuant 3D T1 MRI segmentation. Select between two tracers for metabolic (FDG) and amyloid-based (Florbetapir) analysis and compare visual and statistical (Z-score) comparisons of each normalized regional PET tracer value to normative population data.
Benefits
Reporting options
Choice of reports corresponding to PET tracer used
Clear visualization
Color-coded, graphical reports simplify quantitative reads
24/7 access
Secure access to Cortechs.ai’s secure, cloud-based system from virtually anywhere
Powered by NeuroQuant® for trusted and proven brain segmentation analysis.
Automatically quantifies metabolic tracer bindings localized to brain structures identified by NeuroQuant 3D T1 MRI segmentation. Visual and statistical comparisons of each normalized regional PET tracer value are then compared to normative population data.
Automatically quantifies amyloid-based tracer bindings localized to brain structures identified by NeuroQuant 3D T1 MRI segmentation. Visual and statistical comparisons of each normalized regional PET tracer value are then compared to normative population data.
